Millionaire Fine to Pharmacy Chain

Seven years after Cofasa filed a monopoly complaint against Fischel, in Costa Rica the Commission for the Promotion of Competition decided to impose a fine of almost $19 million on the pharmacy chain.

Tuesday, February 26, 2019

Representatives of the Commission for the Promotion of Competition (Coprocom), informed that the fine imposed on Fischel is provisional, since the resolution is in the appeals phase, so it is not final and cannot be released figures or other aspects of the ruling.

You may be interested in "Pharmaceuticals: Imports up to September 2018"

According to, Cofasa reported in a statement that "... Coprocom considered that the Cefa Fischel group abused its dominant position by performing monopolistic practices in the drug market, harming independent pharmacies and national distributors. In addition, the Cefa Fischel group must behave with respect to free competition and report on it every six months to the Coprocom for such actions."

On the other hand, Cuestamoras Salud, owner of Cefa Central Farmacéutica and the formats Fischel and La Bomba, said in a press release that they will use all legal resources at their disposal to achieve an annulment of the million-dollar fine imposed.

The article adds that the business group Cuestamoras "... rejects 'absolutely and categorically' the resolution. They described it as arbitrary and devoid of any legal basis. Miguel Martí, spokesman for the companies, declared that 'the process was plagued with vices and we were able to demonstrate that Cefa and Fischel always acted in accordance with the law'."

Do you need more information about your business sector?

Request more information:

this site is protected by reCAPTCHA and Google's privacy policy and terms of service.
Need assistance? Contact us
(506) 4001-6423

More on this topic

Coca Cola Fined for Anti-Competitive Practices

July 2012

The penalty imposed by the Commission to Promote Competition in Costa Rica has been upheld after the First Chamber of the Supreme Court declared the last appeal filed by the company irrelevant.

The penalty for monopolistic practices, dating back to May 2004 was because the bottler apparently made exclusive contracts with vendors and fixed prices.

Winners and Losers in Drug Store Wars

July 2012

Corporation Cefa-Fischel is gaining more and more of the market share in Costa Rica, with tactics that are being denounced as anti-competitive business practices.

An article by César Quirós Brenes in reports on up to what point Cefa-Fischel Corporation has reached in the drug retail sector in Costa Rica: "Of the 950 active pharmacies as of 15 June, 67 (7% of total) are Fischel stores.

Pharmacy War Goes to Competition Tribunal

June 2012

In Costa Rica, Compañía Farmacéutica S. A. (Cofasa) has filed a suit over monopolistic acts by the Corporation which owns the Fischel pharmacies .

Cofasa's lawyer, in a complaint before the National Competition Commission at the Ministry of Economy, said that the CEFA Corporation, which owns the pharmacy chain Fischel, "...

Accusations of Anti-Competitive Practices in Insurance Industry

December 2011

The National Insurance Institute of Costa Rica is under investigation for price reductions that could constitute a violation of the Law on Promotion of Competition.

The open procedure by the Commission to Promote Competition (COPROCOM) is the only one that has been presented since the opening of the insurance market in 2008.

 close (x)

Receive more news about Health & Medicine

Suscribe FOR FREE to CentralAmericaDATA EXPRESS.
The most important news of Central America, every day.

Type in your e-mail address:

* Al suscribirse, estará aceptando los terminos y condiciones

Gluten-free food business for sale

Operating Company dedicated to the manufacture of gluten-free and sugar-free products, OHNE brand.
The OHNE brand has 8 product lines: square bread, sweet...

Stock Indexes

(Apr 6)
Dow Jones
S&P 500


(Sep 25)
Brent Crude Oil
Coffee "C"